Related Experiment Video
Updated: Jul 19, 2026
08:46
Real-time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels
Published on: March 22, 2024
B-type natriuretic peptide level in a patient with constrictive pericarditis
1Louisiana State University Health Sciences Center, Earl K Long Medical Center, Baton Rouge, LA 70805, USA.
Summary
Constrictive pericarditis can present with elevated intracavitary pressures but a normal B-type natriuretic peptide (BNP) level. This case highlights potential discrepancies between cardiac pressures and BNP in constrictive pericarditis.
Area of Science:
- Cardiology
- Cardiac Physiology
Background:
- Constrictive pericarditis is a condition characterized by impaired diastolic filling of the heart due to pericardial thickening and restriction.
- B-type natriuretic peptide (BNP) is a biomarker commonly used to assess cardiac strain and heart failure.
Observation:
- A 35-year-old male patient with diagnosed constrictive pericarditis presented with significantly elevated left ventricular end-diastolic pressure (LVEDP) of 35 mmHg.
- Despite the markedly elevated LVEDP, the patient's B-type natriuretic peptide (BNP) level was 129 pg/dl, considered relatively low for such high intracavitary pressures.
Findings:
- The observed discordance between high intracavitary pressures and a low BNP level in constrictive pericarditis suggests that BNP may not always accurately reflect the degree of diastolic dysfunction in this specific condition.
- Potential mechanisms for this discrepancy may involve altered BNP metabolism, release, or receptor sensitivity in the context of chronic pericardial disease.
Implications:
- This case underscores the importance of considering the clinical context and potential limitations of biomarkers like BNP when diagnosing and managing constrictive pericarditis.
- Further research is warranted to elucidate the precise relationship between intracavitary pressures and natriuretic peptide levels in constrictive pericarditis to improve diagnostic accuracy.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:25Pericarditis IV: Nursing Management
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
01:19Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
01:22Pericarditis I: Introduction
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...